None listed
Conditions
Brief summary
Some people who have been treated for non-central nervous system cancers experience problems with cognitive function during and/or after treatment. In this project, an education and skills intervention that was previously delivered successfully for this population by psychologists or occupational therapists in small group format (Responding to Cognitive Concerns, ReCog) and individual online format (eReCog) will be adapted for individual face-to-face delivery by appropriate professionals (ReCog-I) and piloted with a small number of people who have been treated for cancer. This research aims to gather initial evidence about whether the ReCog-I program has an influence on perceived cognitive function and mental health in participants who have been treated for cancer.
Interventions
The intervention to be used is a manualised education and skills training intervention that is designed to be delivered by an appropriately trained and qualified health professional (e.g., psychologist or occupational therapist). The intervention was delivered in 4 one-hour sessions (one-on-one face-to-face and individual online sessions) delivered at weekly intervals facilitated by a provisional psychologist under the supervision of a clinical psychologist. The procedures and manuals for the intervention have been adapted from the existing and previously trialled versions of the "Responding to Cognitive Concerns (ReCog)" intervention. Participants are randomly allocated to either a three- or four-week baseline whereby they complete the cognitive measures at baseline 1 and then the anxiety, depression, sleep, and fatigue measures at all other baselines. Participants then took part in within-session activities and between-session homework tasks (e.g., relaxation practice, applying memory strategies, and applying attention strategies)von the following topics: (1) Ageing, Health, Cancer, and Cognitive Function (2) Memory (3) Attention (4) Fatigue, Emotions, and Cognition.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria are: 18 years and older; fluent in English; previous diagnosis of adult-onset cancer; completion of primary treatments such as surgery, chemotherapy, and radiotherapy; and on a stable dose for at least 2 months for any long-term medication, such as hormonal or targeted therapies.
Exclusion criteria
Exclusion criteria are: childhood cancer history; known primary or secondary central nervous system tumour; current mental disorder that would interfere with the ability to give informed consent and/or participate in the intervention; and history of intracranial radiotherapy or intrathecal chemotherapy.